Opera-1 Trial: Interim Analysis of Safety and Antiviral Activity of Tmc435 in Treatment-naive Genotype 1 Hcv Patients
(2009) 44th Annual Meeting of the European-Association-for-the-Study-of-the-Liver — Location: Copenhagen (Denmark) (22.April.2009)
Files
pdfdocument.pdf
Restricted Access - Adobe PDF
- 51.31 KB
Details
- Authors
- Affiliations
Citations
Manns, M., Horsmans, Y., Reesink, H., Moreno, C., Berg, T., Benhamou, Y., Dusheiko, G., Flisiak, R., Meyvisch, P., Lenz, O., Sekar, V., van’t Klooster, G., Simmen, K., & Verloes, R. (2009). Opera-1 Trial: Interim Analysis of Safety and Antiviral Activity of Tmc435 in Treatment-naive Genotype 1 Hcv Patients. Journal of Hepatology, 50, S7-S7. https://doi.org/10.1016/S0168-8278(09)60013-1 (Original work published 2009)